Karen Duff
British scientist
From Wikipedia, the free encyclopedia
Karen Elizabeth Keitley Duff (born 1965) is a British scientist known for her work on Alzheimer's disease. Her most notable work focused on the development and characterization of mouse models of Alzheimer's disease amyloid deposition.[1][2] She became Centre Director of the UK Dementia Research Institute's hub at University College London in spring 2020.[3]
Karen Duff | |
|---|---|
| |
| Born | 1965 (age 60–61) |
| Alma mater | University of East Anglia Queens' College, Cambridge |
| Awards | Potamkin Prize (2006) |
| Scientific career | |
| Fields | Pathology Cell Biology |
| Institutions | University College London Columbia University New York University University of South Florida |
| Thesis | A study of human and murine cardiac development using molecular genetics methodology (1991) |
| Website | Karen Duff |
She was educated at the University of East Anglia (BSc, 1987) and completed her PhD at Queens' College, Cambridge in 1991. At Cambridge she was a student of Sydney Brenner's department. She was awarded the Potamkin Prize in 2006, together with Karen Ashe and Bradley Hyman.[4] She was formerly Professor of Pathology and Cell Biology at Columbia University.[5] In 2020, she was awarded the British Neuroscience Association Award for Outstanding Contribution to Neuroscience.[6] She was elected a Fellow of the Academy of Medical Sciences in 2022.[7]
She has an h-index of 96 according to Google Scholar.[8]
